ICCR members advocate for the equitable access and affordability of life-saving medicines in low- and middle-income countries.
From pandemic diseases, to neglected tropical diseases (NTDs) and non-communicable diseases (NCDs), ICCR members engage leading pharmaceutical companies in an effort to address global health challenges and promote innovative health programs to help resolve some of the world's most intractable diseases.
Our members believe that global health business models must promote access to health for all, and be equitable and affordable, regardless of one's country or resources.
Featured ICCR Initiative
Sharing Patents. ICCR encourages the world's leading branded pharmaceutical companies to join the Medicines Patent Pool (MPP), which was created by UNITAID, to provide a way for companies to share licenses for their live-saving AIDS medicines for cheaper, generics manufacturing.
Industry-Led Access-To-Medicines Initiatives In Low- And Middle-Income Countries: Strategies And Evidence: An analysis of 21 research-based global biopharmaceutical companies’ strategies for improving access to medicines.
ICCR's Statement of Principles and Recommended Corporate Practices to Promote Global Health: These Principles are an articulation of ICCR's position on corporate responsibility regarding global health, along with our recommended best practices. We welcome affirmation of these Principles and practices by all stakeholders.
The Access to Medicines Index: The Access to Medicine Index ranks pharmaceutical companies’ efforts to improve access to medicine in developing countries.
The Medicines Patent Pool: The MPP aims to lower the prices of HIV medicines and facilitate the development of better-adapted HIV medicines in developing countries. See more: